Hepatitis C Virus Co-Infection Increases the Risk of Anti-Tuberculosis Drug-Induced Hepatotoxicity among Patients with Pulmonary Tuberculosis

BACKGROUND: The country of Georgia has a high prevalence of tuberculosis (TB) and hepatitis C virus (HCV) infection. PURPOSE: To determine whether HCV co-infection increases the risk of incident drug-induced hepatitis among patients on first-line anti-TB drug therapy. METHODS: Prospective cohort stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lomtadze, Nino, Kupreishvili, Lali, Salakaia, Archil, Vashakidze, Sergo, Sharvadze, Lali, Kempker, Russell R., Magee, Matthew J., del Rio, Carlos, Blumberg, Henry M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868578/
https://www.ncbi.nlm.nih.gov/pubmed/24367617
http://dx.doi.org/10.1371/journal.pone.0083892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868578/
https://www.ncbi.nlm.nih.gov/pubmed/24367617
http://dx.doi.org/10.1371/journal.pone.0083892

Ejemplares similares